Aileron Therapeutics (ALRN) Q2 2023 Earnings

11AugConfirmed
Aug 22
Nov 22
Q1 2023
Q2 2023
-1.8
-1.33
-0.86
-0.39

Details

Expected EPS
N/A
Actual EPS
-0.39
Surprise EPS
-0.39
Surprise Percent
+∞%

Description

Aileron Therapeutics (ALRN) has reported earnings of -0.39 per share for Q2 2023.

0 Comments

Share your thoughts